Alpha-amylases and maltase gluco‐amylase are important digestive enzymes that control glucose levels in the treatment of diabetes by lowering postprandial hyperglycaemia (PPHG) levels in animals and humans. This evidence concerns the gene MGAM2 and diabetes mellitus.